On February 13th, LIVZON PHARMA (01513) spent 19.9989 million yuan to repurchase 558,400 A shares.
Lizhu Pharmaceuticals (01513) released an announcement that on February 13, 2025, it invested 1999.89 million yuan (RMB)...
LIVZON PHARMA (01513) announced on February 13, 2025, to spend 19.99 million yuan to repurchase 558,400 A shares, with a repurchase price per share ranging from 35.66 to 35.89 yuan.
Related Articles
Kingfa Sci. & Tech. (600143.SH) is planning to launch an employee stock ownership plan in 2026.
Kingfa Sci. & Tech. (600143.SH) plans to issue up to 39,279,970 restricted shares.
New Stock News | Red Avenue New Materials Group (603650.SH) submits its application to the Hong Kong Stock Exchange. In the first nine months of 2025, its sales revenue in the Chinese semiconductor photoresist market ranked first among Chinese suppliers.
Kingfa Sci. & Tech. (600143.SH) is planning to launch an employee stock ownership plan in 2026.
Kingfa Sci. & Tech. (600143.SH) plans to issue up to 39,279,970 restricted shares.
New Stock News | Red Avenue New Materials Group (603650.SH) submits its application to the Hong Kong Stock Exchange. In the first nine months of 2025, its sales revenue in the Chinese semiconductor photoresist market ranked first among Chinese suppliers.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
